Hoth Therapeutics Inc
NASDAQ:RKTO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of 
Hoth Therapeutics Inc (RKTO) under the Base Case is USD per share.
Compared with the current market price of 0.38 USD, the stock appears .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 5 years, and what happened after valuations like today’s.
Create a free account · No card needed
Fundamental Analysis
What Hoth Therapeutics Does
Hoth Therapeutics is a clinical-stage biopharmaceutical company that develops drug candidates for diseases with limited treatment options, especially in areas like skin disorders, cancer, and inflammatory conditions. It does not sell a broad lineup of commercial medicines yet; instead, it works on turning its research programs into future therapies that can be tested in patients and, if successful, brought to market.
- Headquarters
- United States of America US
- Employees
- 2
- IPO date
- Feb 15, 2019
Revenue & Expenses Breakdown
Hoth Therapeutics Inc
Earnings Waterfall
Hoth Therapeutics Inc
What is the Intrinsic Value of one RKTO stock?
The intrinsic value for Hoth Therapeutics Inc (RKTO) under the Base Case is USD.
Is RKTO stock undervalued or overvalued?
Compared with the current market price of 0.38 USD, the stock appears .
